These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 34859135)

  • 1. Production of Recombinant Replication-defective Lentiviruses Bearing the SARS-CoV or SARS-CoV-2 Attachment Spike Glycoprotein and Their Application in Receptor Tropism and Neutralisation Assays.
    Thakur N; Gallo G; Elreafey AME; Bailey D
    Bio Protoc; 2021 Nov; 11(21):e4249. PubMed ID: 34859135
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Optimized Pseudotyping Conditions for the SARS-COV-2 Spike Glycoprotein.
    Johnson MC; Lyddon TD; Suarez R; Salcedo B; LePique M; Graham M; Ricana C; Robinson C; Ritter DG
    J Virol; 2020 Oct; 94(21):. PubMed ID: 32788194
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterisation of SARS-CoV-2 Lentiviral Pseudotypes and Correlation between Pseudotype-Based Neutralisation Assays and Live Virus-Based Micro Neutralisation Assays.
    Hyseni I; Molesti E; Benincasa L; Piu P; Casa E; Temperton NJ; Manenti A; Montomoli E
    Viruses; 2020 Sep; 12(9):. PubMed ID: 32927639
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The use of Pseudotyped Coronaviruses for the Screening of Entry Inhibitors: Green Tea Extract Inhibits the Entry of SARS-CoV-1, MERSCoV, and SARS-CoV-2 by Blocking Receptor-spike Interaction.
    Joseph J; Karthika T; Das VRA; Raj VS
    Curr Pharm Biotechnol; 2022; 23(8):1118-1129. PubMed ID: 34375189
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pseudotyped Viruses As a Molecular Tool to Monitor Humoral Immune Responses Against SARS-CoV-2 Via Neutralization Assay.
    Fantoni T; Bissoli M; Stefani C; Voi M; Dabija A; Casula R; Minafra DL; da Fonseca Palmeira J; Argañaraz ER; Mayora-Neto M; Temperton NJ; Zipeto D; Ruggiero A
    J Vis Exp; 2023 Nov; (201):. PubMed ID: 38078607
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Optimised Method for the Production and Titration of Lentiviral Vectors Pseudotyped with the SARS-CoV-2 Spike.
    Mekkaoui L; Bentley EM; Ferrari M; Lamb K; Ward K; Karattil R; Akbar Z; Bughda R; Sillibourne J; Onuoha S; Mattiuzzo G; Takeuchi Y; Pule M
    Bio Protoc; 2021 Aug; 11(16):e4194. PubMed ID: 34541054
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human Immunodeficiency Viruses Pseudotyped with SARS-CoV-2 Spike Proteins Infect a Broad Spectrum of Human Cell Lines through Multiple Entry Mechanisms.
    Xu C; Wang A; Geng K; Honnen W; Wang X; Bruiners N; Singh S; Ferrara F; D'Angelo S; Bradbury ARM; Gennaro ML; Liu D; Pinter A; Chang TL
    Viruses; 2021 May; 13(6):. PubMed ID: 34064066
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Establishment of replication-competent vesicular stomatitis virus-based recombinant viruses suitable for SARS-CoV-2 entry and neutralization assays.
    Li H; Zhao C; Zhang Y; Yuan F; Zhang Q; Shi X; Zhang L; Qin C; Zheng A
    Emerg Microbes Infect; 2020 Dec; 9(1):2269-2277. PubMed ID: 32990161
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SARS-CoV-2 Spike Alterations Enhance Pseudoparticle Titers and Replication-Competent VSV-SARS-CoV-2 Virus.
    Havranek KE; Jimenez AR; Acciani MD; Lay Mendoza MF; Reyes Ballista JM; Diaz DA; Brindley MA
    Viruses; 2020 Dec; 12(12):. PubMed ID: 33353101
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A high throughput screening assay for inhibitors of SARS-CoV-2 pseudotyped particle entry.
    Xu M; Pradhan M; Gorshkov K; Petersen JD; Shen M; Guo H; Zhu W; Klumpp-Thomas C; Michael S; Itkin M; Itkin Z; Straus MR; Zimmerberg J; Zheng W; Whittaker GR; Chen CZ
    SLAS Discov; 2022 Mar; 27(2):86-94. PubMed ID: 35086793
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A high throughput screening assay for inhibitors of SARS-CoV-2 pseudotyped particle entry.
    Xu M; Pradhan M; Gorshkov K; Petersen JD; Shen M; Guo H; Zhu W; Klumpp-Thomas C; Michael S; Itkin M; Itkin Z; Straus MR; Zimmerberg J; Zheng W; Whittaker GR; Chen CZ
    bioRxiv; 2021 Oct; ():. PubMed ID: 34642691
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Loss of furin site enhances SARS-CoV-2 spike protein pseudovirus infection.
    Wang Z; Zhong K; Wang G; Lu Q; Li H; Wu Z; Zhang Z; Yang N; Zheng M; Wang Y; Nie C; Zhou L; Tong A
    Gene; 2023 Mar; 856():147144. PubMed ID: 36577450
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effective screening of SARS-CoV-2 neutralizing antibodies in patient serum using lentivirus particles pseudotyped with SARS-CoV-2 spike glycoprotein.
    Tandon R; Mitra D; Sharma P; McCandless MG; Stray SJ; Bates JT; Marshall GD
    Sci Rep; 2020 Nov; 10(1):19076. PubMed ID: 33154514
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Generation of SARS-CoV-2 Spike Pseudotyped Virus for Viral Entry and Neutralization Assays: A 1-Week Protocol.
    Condor Capcha JM; Lambert G; Dykxhoorn DM; Salerno AG; Hare JM; Whitt MA; Pahwa S; Jayaweera DT; Shehadeh LA
    Front Cardiovasc Med; 2020; 7():618651. PubMed ID: 33521067
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SARS-CoV-2 Evolutionary Adaptation toward Host Entry and Recognition of Receptor O-Acetyl Sialylation in Virus-Host Interaction.
    Kim CH
    Int J Mol Sci; 2020 Jun; 21(12):. PubMed ID: 32604730
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Broad and Differential Animal Angiotensin-Converting Enzyme 2 Receptor Usage by SARS-CoV-2.
    Zhao X; Chen D; Szabla R; Zheng M; Li G; Du P; Zheng S; Li X; Song C; Li R; Guo JT; Junop M; Zeng H; Lin H
    J Virol; 2020 Aug; 94(18):. PubMed ID: 32661139
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An optimised method for the production of MERS-CoV spike expressing viral pseudotypes.
    Grehan K; Ferrara F; Temperton N
    MethodsX; 2015; 2():379-84. PubMed ID: 26587388
    [TBL] [Abstract][Full Text] [Related]  

  • 18. S protein of severe acute respiratory syndrome-associated coronavirus mediates entry into hepatoma cell lines and is targeted by neutralizing antibodies in infected patients.
    Hofmann H; Hattermann K; Marzi A; Gramberg T; Geier M; Krumbiegel M; Kuate S; Uberla K; Niedrig M; Pöhlmann S
    J Virol; 2004 Jun; 78(12):6134-42. PubMed ID: 15163706
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-severe acute respiratory syndrome coronavirus spike antibodies trigger infection of human immune cells via a pH- and cysteine protease-independent FcγR pathway.
    Jaume M; Yip MS; Cheung CY; Leung HL; Li PH; Kien F; Dutry I; Callendret B; Escriou N; Altmeyer R; Nal B; Daëron M; Bruzzone R; Peiris JS
    J Virol; 2011 Oct; 85(20):10582-97. PubMed ID: 21775467
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development and effectiveness of pseudotyped SARS-CoV-2 system as determined by neutralizing efficiency and entry inhibition test
    Yang R; Huang B; A R; Li W; Wang W; Deng Y; Tan W
    Biosaf Health; 2020 Dec; 2(4):226-231. PubMed ID: 32864605
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.